Search

Electroencephalographic (EEG) activities reflect the functional state of the brain, but it is difficult to objectively describe functional brain states. Here, we describe two statistical divergence measures, Mahalanobis distance and Hellinger distance of projections to the reference spaces, to evaluate their state-discriminating ability. Last, divergence measures of 30-min segments after caffeine treatment were compared to evaluate the dose- and time-dependent arousal effects of caffeine to the best reference space. EEG was recorded from Sprague-Dawley rats during pre- and post-administration of caffeine. Several two-dimensional reference spaces were constructed from subsets of the normalized 7 relative band powers pooled from the pre-drug period of all recordings for each cortex: two reference spaces from data sets of the frontal and parietal cortex, and four reference spaces from data sets of active wake, slow-wave sleep, paradoxical sleep state, and all states. Sleep-wake states used as test states were plotted onto the reference spaces, and then, two divergence measures were derived to measure state-discriminating ability of each reference space. First, the reference space of the same cortex as test data was better for discriminating test states than another cortical reference space. Second, the one reference space constructed from data of all states was better for discriminating test states than the other reference spaces. Third, divergence measures were well correlated with sleep-wake durations after caffeine administration and showed the temporal trends of caffeine-induced arousal effect. These results suggest that two statistical measures can objectively describe brain functional states and drug-induced states., (Copyright © 2012 Elsevier B.V. All rights reserved.)

The effects of xylazine or medetomidine on tiletamine/zolazepam (Zoletile) anesthesia were evaluated by changes in the canine electroencephalogram (EEG). Experimental groups were three: the group treated with 10 mg/kg of Zoletile intravenously (TZ), the group treated with 1.1 mg/kg of xylazine intramuscularly and 10 mg/kg of Zoletile intravenously (XTZ), and the group treated with 30 microg/kg of medetomidine intramuscularly and 10 mg/kg of Zoletile intravenously (MTZ). EEG recording electrode was positioned at Cz, which was applied to International 10-20 system. For all recording times, the powers of each band (band 1: 1-2.5 Hz, band 2: 2.5-4.5 Hz, band 3: 4.5-8 Hz, band 4: 8-13 Hz, band 5: 13-20 Hz, band 6: 20-30 Hz, band 7: 30-50 Hz, band 8: 1-50 Hz) were calculated. In TZ, at 10 min after Zoletile injection, the powers of bands 3, 4, 5 and 8 significantly decreased. At 20 min after Zoletile injection, the powers of band 1 and 8 were significantly decreased. After Zoletile injection, there were significant decreases in bands 1, 4, 5, 6, 7 and 8 in XTZ, and in bands 1, 3, 4, 5, 6, 7 and 8 in MTZ. These significant changes disappeared in all band powers in TZ and MTZ in the last 1 min just prior to the dogs showing head-up movement. But, in XTZ, all band powers, except band 2, were significantly reduced. EEG power spectral analysis revealed the differences in band powers on awakening, even though the same kind of drugs were used. We thought that was a useful method to compare the effect of xylazine and medetomidine on Zoletile-induced anesthesia in dogs.